Zydus Lifesciences will participate in the J.P. Morgan India Conference 2026 on September 21, 2026. The pharma major issued a regulatory filing to inform investors and exchange members about the upcoming engagement.

The company notified both the Bombay Stock Exchange and the National Stock Exchange of India regarding the schedule. This participation allows management to interact with institutional investors and analysts during the global healthcare event.

Event Details

The conference is part of the broader J.P. Morgan Global Health Care Conference series. Zydus Lifesciences Limited confirmed the date through an official communication signed by its Company Secretary and Compliance Officer, Dhaval N. Soni.

• Event: J.P. Morgan India Conference 2026
• Date: September 21, 2026
• Company: Zydus Lifesciences Limited

No financial results or strategic updates were disclosed in this specific notice. The filing serves solely as a logistical update for market participants.

Zydus Lifesciences Limited conducted its 31st Annual General Meeting through video conferencing on Tuesday, August 11, 2026. The session ran from 10:00 am to 11:16 am IST.

The meeting adhered to the provisions of the Companies Act, 2013 and circulars issued by the Ministry of Corporate Affairs and SEBI. Dhaval N. Soni, Company Secretary and Compliance Officer, assisted Chairman Pankaj R. Patel in conducting the proceedings.

Key Attendees

Directors, key managerial personnel, and auditors attended the meeting via video conferencing or other audio-visual means. The following officials were present:

Procedural Details

Members remained in mute mode during the session to avoid background disturbance. Audio and video were enabled only for pre-registered speakers. The proceedings were recorded and made available on the company website.

The transcript is hosted at www.zyduSlife.com . Ashish Doshi served as the scrutinizer for remote e-voting and e-voting during the AGM.